Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. The company is headquartered in Rockville, Maryland. The company also performs in vitro contract research services. The company is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. Its services also encompass sample processing and custom assays for serology, cell-mediated immunity, viral loads, and bacterial enumeration. Its model services also include syngeneic mouse tumor allograft and select human cell line derived xenograft (CDX) models, and it offers GLP-compliant preclinical testing services in various small animal models. The company provides its services to the federal government, universities and the life science and pharmaceutical industries.
BIOQ stock price ended at $38.5 on 火曜日, after dropping 0.03%
On the latest trading day Jan 06, 2026, the stock price of BIOQ fell by 0.03%, dropping from $38.50 to $38.50. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $38.50 and a high of $38.50. On the latest trading day, the trading volume for BIOQ decreased by 75 shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 208 shares were traded, with a market value of approximately $34.2M.